Catalyst Wire Dossier Catalyst Wire Dossier

Umbilical cord tissue-derived mesenchymal stem cells

· Translational Biosciences
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Umbilical cord tissue-derived mesenchymal stem cells, covering 2019-06-20 to 2019-06-20. Get the full timeline:

Most recent: Clinical Trial Update: Umbilical Cord Tissue-derived Mesenchymal Stem Cells for Rheumatoid Arthritis [Phase 1, Phase 2]

See pricing